nodes	percent_of_prediction	percent_of_DWPC	metapath
Amoxapine—HTR7—umbilical artery—type 1 diabetes mellitus	0.0566	0.215	CbGeAlD
Amoxapine—HTR2A—arteriole—type 1 diabetes mellitus	0.0203	0.077	CbGeAlD
Amoxapine—ORM1—saliva—type 1 diabetes mellitus	0.0188	0.0715	CbGeAlD
Amoxapine—SLC6A2—autonomic nervous system—type 1 diabetes mellitus	0.0144	0.0549	CbGeAlD
Amoxapine—HTR7—autonomic nervous system—type 1 diabetes mellitus	0.0139	0.0529	CbGeAlD
Amoxapine—DRD1—nerve—type 1 diabetes mellitus	0.0125	0.0476	CbGeAlD
Amoxapine—HTR3A—nerve—type 1 diabetes mellitus	0.0121	0.046	CbGeAlD
Amoxapine—Inappropriate antidiuretic hormone secretion—Ramipril—type 1 diabetes mellitus	0.0114	0.0589	CcSEcCtD
Amoxapine—SLC6A3—nerve—type 1 diabetes mellitus	0.0101	0.0383	CbGeAlD
Amoxapine—HTR7—peripheral nervous system—type 1 diabetes mellitus	0.01	0.0382	CbGeAlD
Amoxapine—HTR2A—autonomic nervous system—type 1 diabetes mellitus	0.00868	0.033	CbGeAlD
Amoxapine—SLC6A2—nerve—type 1 diabetes mellitus	0.00812	0.0309	CbGeAlD
Amoxapine—HTR7—nerve—type 1 diabetes mellitus	0.00783	0.0298	CbGeAlD
Amoxapine—Disturbance in attention—Ramipril—type 1 diabetes mellitus	0.00765	0.0395	CcSEcCtD
Amoxapine—DRD2—nerve—type 1 diabetes mellitus	0.0074	0.0281	CbGeAlD
Amoxapine—ADRA2A—peripheral nervous system—type 1 diabetes mellitus	0.00736	0.028	CbGeAlD
Amoxapine—Vasculitis—Ramipril—type 1 diabetes mellitus	0.00679	0.035	CcSEcCtD
Amoxapine—HTR2A—peripheral nervous system—type 1 diabetes mellitus	0.00626	0.0238	CbGeAlD
Amoxapine—Gynaecomastia—Ramipril—type 1 diabetes mellitus	0.00593	0.0306	CcSEcCtD
Amoxapine—HTR3A—islet of Langerhans—type 1 diabetes mellitus	0.00586	0.0223	CbGeAlD
Amoxapine—Vascular purpura—Ramipril—type 1 diabetes mellitus	0.00538	0.0278	CcSEcCtD
Amoxapine—Nasal congestion—Ramipril—type 1 diabetes mellitus	0.00528	0.0273	CcSEcCtD
Amoxapine—Libido decreased—Ramipril—type 1 diabetes mellitus	0.00519	0.0268	CcSEcCtD
Amoxapine—Atrial fibrillation—Ramipril—type 1 diabetes mellitus	0.00508	0.0262	CcSEcCtD
Amoxapine—Purpura—Ramipril—type 1 diabetes mellitus	0.00499	0.0258	CcSEcCtD
Amoxapine—Cerebrovascular accident—Ramipril—type 1 diabetes mellitus	0.00491	0.0253	CcSEcCtD
Amoxapine—HTR2A—nerve—type 1 diabetes mellitus	0.00488	0.0186	CbGeAlD
Amoxapine—Disturbance in sexual arousal—Ramipril—type 1 diabetes mellitus	0.00477	0.0246	CcSEcCtD
Amoxapine—Eosinophilia—Ramipril—type 1 diabetes mellitus	0.00412	0.0212	CcSEcCtD
Amoxapine—Pancreatitis—Ramipril—type 1 diabetes mellitus	0.00408	0.021	CcSEcCtD
Amoxapine—Erectile dysfunction—Ramipril—type 1 diabetes mellitus	0.00383	0.0198	CcSEcCtD
Amoxapine—Weight increased—Ramipril—type 1 diabetes mellitus	0.00379	0.0195	CcSEcCtD
Amoxapine—Asenapine—ADRB1—type 1 diabetes mellitus	0.00376	0.287	CrCbGaD
Amoxapine—Acute coronary syndrome—Ramipril—type 1 diabetes mellitus	0.00366	0.0189	CcSEcCtD
Amoxapine—Myocardial infarction—Ramipril—type 1 diabetes mellitus	0.00364	0.0188	CcSEcCtD
Amoxapine—Jaundice—Ramipril—type 1 diabetes mellitus	0.00361	0.0186	CcSEcCtD
Amoxapine—Stomatitis—Ramipril—type 1 diabetes mellitus	0.00361	0.0186	CcSEcCtD
Amoxapine—HTR1B—cardiovascular system—type 1 diabetes mellitus	0.00356	0.0135	CbGeAlD
Amoxapine—Agranulocytosis—Ramipril—type 1 diabetes mellitus	0.00346	0.0179	CcSEcCtD
Amoxapine—Hepatitis—Ramipril—type 1 diabetes mellitus	0.00333	0.0172	CcSEcCtD
Amoxapine—CHRM1—cardiovascular system—type 1 diabetes mellitus	0.00322	0.0122	CbGeAlD
Amoxapine—HTR2B—cardiovascular system—type 1 diabetes mellitus	0.0032	0.0122	CbGeAlD
Amoxapine—Tinnitus—Ramipril—type 1 diabetes mellitus	0.0031	0.016	CcSEcCtD
Amoxapine—DRD2—retina—type 1 diabetes mellitus	0.00307	0.0117	CbGeAlD
Amoxapine—Alopecia—Ramipril—type 1 diabetes mellitus	0.00294	0.0152	CcSEcCtD
Amoxapine—HTR1A—cardiovascular system—type 1 diabetes mellitus	0.00287	0.0109	CbGeAlD
Amoxapine—Tension—Ramipril—type 1 diabetes mellitus	0.00284	0.0147	CcSEcCtD
Amoxapine—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.00284	0.0146	CcSEcCtD
Amoxapine—Nervousness—Ramipril—type 1 diabetes mellitus	0.00281	0.0145	CcSEcCtD
Amoxapine—ADRA2A—islet of Langerhans—type 1 diabetes mellitus	0.00278	0.0106	CbGeAlD
Amoxapine—HTR7—cardiovascular system—type 1 diabetes mellitus	0.00274	0.0104	CbGeAlD
Amoxapine—Tremor—Ramipril—type 1 diabetes mellitus	0.00272	0.014	CcSEcCtD
Amoxapine—HTR7—kidney—type 1 diabetes mellitus	0.00268	0.0102	CbGeAlD
Amoxapine—Agitation—Ramipril—type 1 diabetes mellitus	0.00266	0.0137	CcSEcCtD
Amoxapine—ADRA1A—cardiovascular system—type 1 diabetes mellitus	0.00265	0.0101	CbGeAlD
Amoxapine—Syncope—Ramipril—type 1 diabetes mellitus	0.0026	0.0134	CcSEcCtD
Amoxapine—Leukopenia—Ramipril—type 1 diabetes mellitus	0.00259	0.0134	CcSEcCtD
Amoxapine—Palpitations—Ramipril—type 1 diabetes mellitus	0.00256	0.0132	CcSEcCtD
Amoxapine—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.00255	0.0131	CcSEcCtD
Amoxapine—Convulsion—Ramipril—type 1 diabetes mellitus	0.00251	0.013	CcSEcCtD
Amoxapine—Olanzapine—CHRM2—type 1 diabetes mellitus	0.00246	0.187	CrCbGaD
Amoxapine—Dry mouth—Ramipril—type 1 diabetes mellitus	0.00241	0.0124	CcSEcCtD
Amoxapine—Confusional state—Ramipril—type 1 diabetes mellitus	0.00238	0.0123	CcSEcCtD
Amoxapine—Oedema—Ramipril—type 1 diabetes mellitus	0.00237	0.0122	CcSEcCtD
Amoxapine—Shock—Ramipril—type 1 diabetes mellitus	0.00233	0.012	CcSEcCtD
Amoxapine—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.00232	0.0119	CcSEcCtD
Amoxapine—Tachycardia—Ramipril—type 1 diabetes mellitus	0.00231	0.0119	CcSEcCtD
Amoxapine—Anorexia—Ramipril—type 1 diabetes mellitus	0.00225	0.0116	CcSEcCtD
Amoxapine—ADRA1A—lymphoid tissue—type 1 diabetes mellitus	0.00222	0.00845	CbGeAlD
Amoxapine—Hypotension—Ramipril—type 1 diabetes mellitus	0.00221	0.0114	CcSEcCtD
Amoxapine—Insomnia—Ramipril—type 1 diabetes mellitus	0.00214	0.011	CcSEcCtD
Amoxapine—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.00212	0.011	CcSEcCtD
Amoxapine—Somnolence—Ramipril—type 1 diabetes mellitus	0.0021	0.0108	CcSEcCtD
Amoxapine—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.00208	0.0107	CcSEcCtD
Amoxapine—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.00206	0.0106	CcSEcCtD
Amoxapine—Fatigue—Ramipril—type 1 diabetes mellitus	0.00204	0.0105	CcSEcCtD
Amoxapine—Constipation—Ramipril—type 1 diabetes mellitus	0.00202	0.0104	CcSEcCtD
Amoxapine—HTR2A—retina—type 1 diabetes mellitus	0.00202	0.00769	CbGeAlD
Amoxapine—ADRA2A—pancreas—type 1 diabetes mellitus	0.00196	0.00743	CbGeAlD
Amoxapine—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.00195	0.0101	CcSEcCtD
Amoxapine—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.00193	0.00998	CcSEcCtD
Amoxapine—Urticaria—Ramipril—type 1 diabetes mellitus	0.00188	0.00969	CcSEcCtD
Amoxapine—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.00187	0.00965	CcSEcCtD
Amoxapine—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.00187	0.00965	CcSEcCtD
Amoxapine—HTR2A—cardiovascular system—type 1 diabetes mellitus	0.00171	0.0065	CbGeAlD
Amoxapine—Asthenia—Ramipril—type 1 diabetes mellitus	0.0017	0.00876	CcSEcCtD
Amoxapine—Pruritus—Ramipril—type 1 diabetes mellitus	0.00167	0.00863	CcSEcCtD
Amoxapine—HTR2A—kidney—type 1 diabetes mellitus	0.00167	0.00636	CbGeAlD
Amoxapine—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.00162	0.00835	CcSEcCtD
Amoxapine—Dizziness—Ramipril—type 1 diabetes mellitus	0.00156	0.00807	CcSEcCtD
Amoxapine—Loxapine—CHRM2—type 1 diabetes mellitus	0.00153	0.117	CrCbGaD
Amoxapine—CYP2D6—kidney—type 1 diabetes mellitus	0.00152	0.0058	CbGeAlD
Amoxapine—Vomiting—Ramipril—type 1 diabetes mellitus	0.0015	0.00776	CcSEcCtD
Amoxapine—Rash—Ramipril—type 1 diabetes mellitus	0.00149	0.00769	CcSEcCtD
Amoxapine—Dermatitis—Ramipril—type 1 diabetes mellitus	0.00149	0.00769	CcSEcCtD
Amoxapine—Quetiapine—CHRM2—type 1 diabetes mellitus	0.00149	0.114	CrCbGaD
Amoxapine—Headache—Ramipril—type 1 diabetes mellitus	0.00148	0.00764	CcSEcCtD
Amoxapine—Nausea—Ramipril—type 1 diabetes mellitus	0.0014	0.00725	CcSEcCtD
Amoxapine—Loxapine—ADRB1—type 1 diabetes mellitus	0.0013	0.0993	CrCbGaD
Amoxapine—Clozapine—CHRM2—type 1 diabetes mellitus	0.00128	0.0978	CrCbGaD
Amoxapine—Olanzapine—ALB—type 1 diabetes mellitus	0.000841	0.0642	CrCbGaD
Amoxapine—Diazepam—ALB—type 1 diabetes mellitus	0.000444	0.0339	CrCbGaD
Amoxapine—HTR7—Signaling Pathways—INS—type 1 diabetes mellitus	4.12e-05	7.78e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	4.11e-05	7.76e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—TYK2—type 1 diabetes mellitus	4.06e-05	7.65e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—IGF2—type 1 diabetes mellitus	4.04e-05	7.62e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—INS—type 1 diabetes mellitus	4.01e-05	7.57e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	4e-05	7.54e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—VAV1—type 1 diabetes mellitus	4e-05	7.54e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—IGF1—type 1 diabetes mellitus	3.99e-05	7.53e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—TYK2—type 1 diabetes mellitus	3.99e-05	7.53e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—IGF1—type 1 diabetes mellitus	3.99e-05	7.52e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—CD80—type 1 diabetes mellitus	3.99e-05	7.52e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CXCL10—type 1 diabetes mellitus	3.98e-05	7.52e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—TYK2—type 1 diabetes mellitus	3.98e-05	7.52e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—ERBB3—type 1 diabetes mellitus	3.98e-05	7.5e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—IGF2—type 1 diabetes mellitus	3.98e-05	7.5e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling by GPCR—EGFR—type 1 diabetes mellitus	3.97e-05	7.5e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—TYK2—type 1 diabetes mellitus	3.97e-05	7.49e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling by GPCR—EGFR—type 1 diabetes mellitus	3.97e-05	7.49e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—IGF2—type 1 diabetes mellitus	3.97e-05	7.49e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—IGF2—type 1 diabetes mellitus	3.96e-05	7.46e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—INS—type 1 diabetes mellitus	3.95e-05	7.45e-05	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.95e-05	7.45e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—CCR5—type 1 diabetes mellitus	3.93e-05	7.42e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—CCR5—type 1 diabetes mellitus	3.91e-05	7.38e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—TYK2—type 1 diabetes mellitus	3.91e-05	7.37e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—IGF2—type 1 diabetes mellitus	3.89e-05	7.35e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CD86—type 1 diabetes mellitus	3.89e-05	7.34e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—IGF1—type 1 diabetes mellitus	3.88e-05	7.32e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	3.87e-05	7.31e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling by GPCR—EGFR—type 1 diabetes mellitus	3.86e-05	7.28e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—IL2RA—type 1 diabetes mellitus	3.85e-05	7.27e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—IL2—type 1 diabetes mellitus	3.85e-05	7.25e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CD86—type 1 diabetes mellitus	3.83e-05	7.22e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—IL2—type 1 diabetes mellitus	3.83e-05	7.22e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CD86—type 1 diabetes mellitus	3.82e-05	7.21e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—IGF1—type 1 diabetes mellitus	3.82e-05	7.2e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CD86—type 1 diabetes mellitus	3.81e-05	7.19e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling by GPCR—EGFR—type 1 diabetes mellitus	3.8e-05	7.17e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—INS—type 1 diabetes mellitus	3.77e-05	7.11e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—CD80—type 1 diabetes mellitus	3.76e-05	7.09e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CD86—type 1 diabetes mellitus	3.75e-05	7.07e-05	CbGpPWpGaD
Amoxapine—DRD2—GPCR downstream signaling—IL2—type 1 diabetes mellitus	3.72e-05	7.01e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—CD80—type 1 diabetes mellitus	3.71e-05	7e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—E2F1—type 1 diabetes mellitus	3.69e-05	6.97e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.69e-05	6.96e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.68e-05	6.95e-05	CbGpPWpGaD
Amoxapine—HTR2A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	3.66e-05	6.9e-05	CbGpPWpGaD
Amoxapine—HRH1—GPCR downstream signaling—IL2—type 1 diabetes mellitus	3.65e-05	6.89e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—IGF1—type 1 diabetes mellitus	3.64e-05	6.88e-05	CbGpPWpGaD
Amoxapine—CHRM1—GPCR downstream signaling—IL2—type 1 diabetes mellitus	3.64e-05	6.86e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—E2F1—type 1 diabetes mellitus	3.63e-05	6.86e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—TYK2—type 1 diabetes mellitus	3.63e-05	6.85e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling by GPCR—EGFR—type 1 diabetes mellitus	3.63e-05	6.84e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—E2F1—type 1 diabetes mellitus	3.63e-05	6.84e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.62e-05	6.83e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—IGF2—type 1 diabetes mellitus	3.62e-05	6.83e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.62e-05	6.82e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—E2F1—type 1 diabetes mellitus	3.61e-05	6.82e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.58e-05	6.76e-05	CbGpPWpGaD
Amoxapine—ADRA1A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	3.58e-05	6.76e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—E2F1—type 1 diabetes mellitus	3.56e-05	6.71e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—INS—type 1 diabetes mellitus	3.55e-05	6.7e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.53e-05	6.65e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.52e-05	6.64e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—ERBB3—type 1 diabetes mellitus	3.51e-05	6.62e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—INS—type 1 diabetes mellitus	3.51e-05	6.61e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CD86—type 1 diabetes mellitus	3.48e-05	6.57e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.46e-05	6.53e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	3.45e-05	6.51e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CCR5—type 1 diabetes mellitus	3.45e-05	6.51e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	3.45e-05	6.5e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—IGF1—type 1 diabetes mellitus	3.44e-05	6.48e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	3.43e-05	6.48e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	3.42e-05	6.45e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—IL2RA—type 1 diabetes mellitus	3.4e-05	6.42e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CCR5—type 1 diabetes mellitus	3.4e-05	6.41e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—IGF1—type 1 diabetes mellitus	3.39e-05	6.4e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CCR5—type 1 diabetes mellitus	3.39e-05	6.39e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	3.38e-05	6.38e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CCR5—type 1 diabetes mellitus	3.38e-05	6.37e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—IL2—type 1 diabetes mellitus	3.38e-05	6.37e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling by GPCR—EGFR—type 1 diabetes mellitus	3.37e-05	6.37e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.37e-05	6.35e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	3.35e-05	6.31e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	3.34e-05	6.3e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—GCG—type 1 diabetes mellitus	3.33e-05	6.28e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	3.33e-05	6.28e-05	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	3.33e-05	6.28e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CCR5—type 1 diabetes mellitus	3.33e-05	6.27e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—IL2—type 1 diabetes mellitus	3.32e-05	6.27e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—IL2—type 1 diabetes mellitus	3.31e-05	6.25e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—E2F1—type 1 diabetes mellitus	3.31e-05	6.24e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.3e-05	6.23e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—IL2—type 1 diabetes mellitus	3.3e-05	6.23e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	3.28e-05	6.18e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—IL2—type 1 diabetes mellitus	3.25e-05	6.14e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—CD80—type 1 diabetes mellitus	3.23e-05	6.1e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—CD80—type 1 diabetes mellitus	3.22e-05	6.07e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.17e-05	5.99e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	3.14e-05	5.93e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.13e-05	5.91e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.12e-05	5.88e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CCR5—type 1 diabetes mellitus	3.09e-05	5.83e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.07e-05	5.8e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.07e-05	5.8e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.07e-05	5.79e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—IL2—type 1 diabetes mellitus	3.07e-05	5.79e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—IL2—type 1 diabetes mellitus	3.07e-05	5.78e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—INS—type 1 diabetes mellitus	3.06e-05	5.76e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.05e-05	5.76e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.05e-05	5.75e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	3.05e-05	5.75e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—INS—type 1 diabetes mellitus	3.04e-05	5.73e-05	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—IL6—type 1 diabetes mellitus	3.03e-05	5.72e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—IL2—type 1 diabetes mellitus	3.02e-05	5.7e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.99e-05	5.63e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—IL2—type 1 diabetes mellitus	2.98e-05	5.63e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling by GPCR—IL6—type 1 diabetes mellitus	2.97e-05	5.6e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—IGF1—type 1 diabetes mellitus	2.96e-05	5.58e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	2.94e-05	5.55e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—IGF1—type 1 diabetes mellitus	2.94e-05	5.55e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.94e-05	5.54e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—IL2—type 1 diabetes mellitus	2.93e-05	5.54e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—EGFR—type 1 diabetes mellitus	2.93e-05	5.52e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling by GPCR—IL6—type 1 diabetes mellitus	2.92e-05	5.51e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—INS—type 1 diabetes mellitus	2.87e-05	5.42e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CD80—type 1 diabetes mellitus	2.84e-05	5.36e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—CAT—type 1 diabetes mellitus	2.82e-05	5.32e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.81e-05	5.29e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—IL2—type 1 diabetes mellitus	2.8e-05	5.28e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CD80—type 1 diabetes mellitus	2.79e-05	5.27e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CD80—type 1 diabetes mellitus	2.79e-05	5.26e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling by GPCR—IL6—type 1 diabetes mellitus	2.79e-05	5.26e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CD80—type 1 diabetes mellitus	2.78e-05	5.24e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CD80—type 1 diabetes mellitus	2.74e-05	5.16e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—TYK2—type 1 diabetes mellitus	2.73e-05	5.15e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—TYK2—type 1 diabetes mellitus	2.72e-05	5.12e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—INS—type 1 diabetes mellitus	2.68e-05	5.06e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—NOS3—type 1 diabetes mellitus	2.68e-05	5.06e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—NOS3—type 1 diabetes mellitus	2.67e-05	5.03e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.65e-05	4.99e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—IL2—type 1 diabetes mellitus	2.64e-05	4.98e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—INS—type 1 diabetes mellitus	2.64e-05	4.98e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—INS—type 1 diabetes mellitus	2.63e-05	4.97e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—ALB—type 1 diabetes mellitus	2.63e-05	4.97e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling by GPCR—IL6—type 1 diabetes mellitus	2.63e-05	4.96e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—INS—type 1 diabetes mellitus	2.63e-05	4.95e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.61e-05	4.92e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—IL2—type 1 diabetes mellitus	2.61e-05	4.92e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—IGF1—type 1 diabetes mellitus	2.59e-05	4.9e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling by GPCR—IL6—type 1 diabetes mellitus	2.59e-05	4.89e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—INS—type 1 diabetes mellitus	2.58e-05	4.88e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.58e-05	4.87e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—EGFR—type 1 diabetes mellitus	2.58e-05	4.87e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.58e-05	4.87e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—IGF1—type 1 diabetes mellitus	2.55e-05	4.82e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—IGF1—type 1 diabetes mellitus	2.55e-05	4.81e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CD80—type 1 diabetes mellitus	2.54e-05	4.79e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	2.54e-05	4.79e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—IGF1—type 1 diabetes mellitus	2.54e-05	4.79e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	2.54e-05	4.78e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	2.53e-05	4.77e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—NOS3—type 1 diabetes mellitus	2.52e-05	4.75e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.51e-05	4.73e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—IGF1—type 1 diabetes mellitus	2.5e-05	4.72e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	2.49e-05	4.69e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.47e-05	4.66e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—INS—type 1 diabetes mellitus	2.4e-05	4.53e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—TYK2—type 1 diabetes mellitus	2.4e-05	4.52e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—TYK2—type 1 diabetes mellitus	2.36e-05	4.45e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.36e-05	4.45e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—TYK2—type 1 diabetes mellitus	2.35e-05	4.44e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—NOS3—type 1 diabetes mellitus	2.35e-05	4.44e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.35e-05	4.43e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—TYK2—type 1 diabetes mellitus	2.35e-05	4.43e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.34e-05	4.42e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—IGF1—type 1 diabetes mellitus	2.32e-05	4.38e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—NOS3—type 1 diabetes mellitus	2.31e-05	4.37e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	2.31e-05	4.36e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—NOS3—type 1 diabetes mellitus	2.31e-05	4.36e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—TYK2—type 1 diabetes mellitus	2.31e-05	4.36e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—NOS3—type 1 diabetes mellitus	2.3e-05	4.34e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.28e-05	4.3e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.27e-05	4.29e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—IL2—type 1 diabetes mellitus	2.27e-05	4.29e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—NOS3—type 1 diabetes mellitus	2.27e-05	4.28e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.26e-05	4.27e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—IL6—type 1 diabetes mellitus	2.26e-05	4.26e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—IL2—type 1 diabetes mellitus	2.26e-05	4.26e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—IL6—type 1 diabetes mellitus	2.25e-05	4.24e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.24e-05	4.23e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.22e-05	4.19e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.19e-05	4.14e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—TYK2—type 1 diabetes mellitus	2.15e-05	4.05e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.14e-05	4.04e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—NOS3—type 1 diabetes mellitus	2.11e-05	3.97e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.02e-05	3.81e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CASP3—type 1 diabetes mellitus	2e-05	3.77e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—IL2—type 1 diabetes mellitus	1.99e-05	3.76e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.99e-05	3.76e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—IL6—type 1 diabetes mellitus	1.98e-05	3.74e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CASP3—type 1 diabetes mellitus	1.97e-05	3.71e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—IL2—type 1 diabetes mellitus	1.96e-05	3.7e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CASP3—type 1 diabetes mellitus	1.96e-05	3.7e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—IL2—type 1 diabetes mellitus	1.96e-05	3.69e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CASP3—type 1 diabetes mellitus	1.95e-05	3.69e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—IL6—type 1 diabetes mellitus	1.95e-05	3.68e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—IL2—type 1 diabetes mellitus	1.95e-05	3.68e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—IL6—type 1 diabetes mellitus	1.95e-05	3.68e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—IL6—type 1 diabetes mellitus	1.94e-05	3.66e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CASP3—type 1 diabetes mellitus	1.92e-05	3.63e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—IL2—type 1 diabetes mellitus	1.92e-05	3.62e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—IL6—type 1 diabetes mellitus	1.91e-05	3.61e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.91e-05	3.61e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.9e-05	3.59e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—INS—type 1 diabetes mellitus	1.87e-05	3.53e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—IL6—type 1 diabetes mellitus	1.8e-05	3.4e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—IL6—type 1 diabetes mellitus	1.8e-05	3.4e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CASP3—type 1 diabetes mellitus	1.79e-05	3.37e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—IL2—type 1 diabetes mellitus	1.79e-05	3.37e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—IL6—type 1 diabetes mellitus	1.78e-05	3.35e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—IL6—type 1 diabetes mellitus	1.75e-05	3.31e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.74e-05	3.28e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.73e-05	3.26e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—IL6—type 1 diabetes mellitus	1.72e-05	3.25e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—ALB—type 1 diabetes mellitus	1.72e-05	3.24e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.68e-05	3.17e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.65e-05	3.12e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.65e-05	3.11e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—IL6—type 1 diabetes mellitus	1.65e-05	3.11e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.64e-05	3.1e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—NOS3—type 1 diabetes mellitus	1.64e-05	3.1e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.62e-05	3.05e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—IL6—type 1 diabetes mellitus	1.55e-05	2.93e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—IL6—type 1 diabetes mellitus	1.53e-05	2.89e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.53e-05	2.88e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.5e-05	2.83e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.5e-05	2.83e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.5e-05	2.83e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.49e-05	2.82e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.47e-05	2.77e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.37e-05	2.58e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—IL6—type 1 diabetes mellitus	1.34e-05	2.52e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—IL6—type 1 diabetes mellitus	1.33e-05	2.51e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—IL6—type 1 diabetes mellitus	1.17e-05	2.21e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—IL6—type 1 diabetes mellitus	1.15e-05	2.18e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—IL6—type 1 diabetes mellitus	1.15e-05	2.17e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—IL6—type 1 diabetes mellitus	1.15e-05	2.16e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—IL6—type 1 diabetes mellitus	1.13e-05	2.13e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—IL6—type 1 diabetes mellitus	1.05e-05	1.98e-05	CbGpPWpGaD
